FDA Adverse Event Injury Summary report: N

ETHIBOND EXTRA & EXCEL POLYESTER SUTURE UNKNOWN

MDR report key: 16620490 · Received March 27, 2023

Report

Report Number
2210968-2023-02094
Event Type
Injury
Date Received
March 27, 2023
Date of Event
March 10, 2022
Manufacturer
ETHICON INC.
Product Code
GAT
PMA / PMN Number
K946173
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

(B)(4). THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY ETHICON INC, OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, ETHICON INC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE. ATTEMPTS ARE BEING MADE TO OBTAIN THE FOLLOWING INFORMATION. TO DATE NO RESPONSE HAS BEEN PROVIDED. IF FURTHER DETAILS ARE RECEIVED AT A LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. DOES THE SURGEON BELIEVE THAT ANY OF THE ETHICON PRODUCTS INVOLVED CAUSED AND/OR CONTRIBUTED TO THE POST-OPERATIVE COMPLICATIONS DESCRIBED IN THE ARTICLE? WHICH SPECIFIC ETHICON PRODUCTS HAVE BEEN USED DURING THE PROCEDURES (PRODUCT CODE, LOT NUMBER)? DOES THE SURGEON BELIEVE THERE WAS ANY DEFICIENCY WITH ANY OF THE ETHICON PRODUCTS USED IN THIS PROCEDURE? IF SO, PLEASE PROVIDE DETAILS. WERE THE CASES DISCUSSED IN THIS ARTICLE PREVIOUSLY REPORTED TO ETHICON? IF YES, PLEASE PROVIDE A COMPLAINT REFERENCE NUMBER. PATIENT DEMOGRAPHICS? THIS REPORT IS RELATED TO A JOURNAL ARTICLE; THEREFORE, NO PRODUCT WILL BE RETURNED FOR ANALYSIS AND THE BATCH HISTORY RECORDS CANNOT BE REVIEWED AS THE LOT NUMBER HAS NOT BEEN PROVIDED. COMPONENT CODE: G07002 ¿ DEVICE NOT RETURNED. THE SINGLE COMPLAINT WAS REPORTED WITH MULTIPLE EVENTS. THERE ARE NO ADDITIONAL DETAILS REGARDING THE ADDITIONAL EVENTS. RELATED EVENTS CAPTURED VIA 2210968-2023-02076, 2210968-2023-02077, 2210968-2023-02079, 2210968-2023-02080, 2210968-2023-02081, 2210968-2023-02083, 2210968-2023-02084, 2210968-2023-02085 AND 2210968-2023-02086. CITATION: HTTPS://DOI.ORG/10.1007/S00192-022-05134-4.

Description of Event or Problem · 0

TITLE: A ROBOTIC APPROACH TO MANAGEMENT OF FAILED SACROCOLPOPEXY AND SACROCOLPOPEXY COMPLICATIONS: A CASE SERIES. THIS IS A RETROSPECTIVE CASE SERIES OF PATIENTS WHO UNDERWENT REVISION OF SCP BETWEEN JANUARY 2014 AND JANUARY 2021 AT A SINGLE INSTITUTION. NINETEEN PATIENTS WERE INITIALLY IDENTIFIED BY CPT CODES; TEN MET THE INCLUSION CRITERIA. Y MESH , 0 ETHIBOND SUTURE POLYPROPYLENE MESH WERE USED. REPORTED COMPLICATIONS INCLUDED PATIENT 1- 61 YEARS OLD: MESH INTACT DETACHED FROM VAGINA, BOWEL ADHESIONS TO MESH. PATIENT 3 - 55 YEARS OLD : MESH INTACT LOOSELY ATTACHED TO THE ANTERIOR LONGITUDINAL LIGAMENT. PATIENT 5 - 50 YEARS OLD : MESH INTACT DETACHED FROM VAGINA. PATIENT 6 - 70 YEARS OLD : MESH INTACT, DETACHED FROM CERVIX, MULTIPLE BOWEL ADHESIONS TO MESH AND VAGINA. PATIENT 8 - 53 YEARS OLD : SEROSANGUINOUS FLUID COLLECTION OVERLYING MESH ON ANTERIOR CERVIX WITH ETHIBOND SUTURES. PATIENT 9 - 77 YEARS OLD :SEROSANGUINOUS FLUID COLLECTION OVERLYING MESH, MESH EXPOSURE INTO THE VAGINA, BOWEL ADHESIONS TO THE VAGINAL APEX AND MESH, NEGATIVE SIGMOID BUBBLE TEST. IN CONCLUSION PROLAPSE RECURRENCE AND COMPLICATIONS AFTER SCP HAVE A SIGNIFICANT IMPACT ON PATIENT QUALITY OF LIFE. RECURRENT PROLAPSE AFTER SCP THEORETICALLY OCCURS BECAUSE OF MESH DETACHMENT FROM THE CERVIX/VAGINA, THE ANTERIOR LONGITUDINAL LIGAMENT, OR DISRUPTION/STRETCHING OF THE MESH. OUR CASE SERIES DEMONSTRATES THAT ABDOMINAL RE-EXPLORATION IS FEASIBLE AND VALUABLE IN THESE RARE CASES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1809089 ETHIBOND EXTRA & EXCEL POLYESTER SUTURE UNKNOWN SUTURE, NONABSORBABLE, SYNTHETIC, POLYETHYLENE GAT ETHICON INC.

Patients

Seq Age Sex Outcome Treatment
1 55 YR Unknown Required Intervention